Regulation of urokinase receptor expression in colon cancer
Regulation of urokinase receptor expression in colon cancer
批准号:
7866600
负责人:
Douglas D. Boyd
金额:
$26.32万
依托单位国家:
美国
项目类别:
财政年份:
1994
资助国家:
美国
项目状态:
已结题
起止时间:
1994-07-01 至 2011-12-30
关键词:
BindingCell surfaceColon CarcinomaEnhancersExtracellular MatrixExtracellular Matrix ProteinsFibrinGene ExpressionGenesGrowthHypoxiaIntronsLacZ GenesLibrariesLymphokine-Activated Killer CellsMusNatureNeoplasm MetastasisNutrientPlacentaPlasminPlayPopulationPost-Transcriptional RegulationPrevalenceProteinsProteolysisRegulationReporterSerine ProteaseSkinSmall Interfering RNAStimulusStressThrombusTimeTissuesTranscriptional RegulationTransfectionUrokinaseUrokinase Plasminogen Activator ReceptorWorkabstractingbasecancer celldensitydeprivationgenome-wideglycosylationkillingsneoplastic cellnovelprotein degradationreceptorreceptor expressionresearch studytranscription factortumortumor growth
中文摘要
大量研究表明,细胞表面尿激酶受体(u-PAR)参与调节肿瘤的生长和发展。较高的u-PAR水平促进生长,而较低的u-PAR促进肿瘤休眠,后者保护肿瘤免受微环境压力,如缺氧、营养缺乏等。U-PAR还与丝氨酸蛋白水解酶尿激酶结合,从而增加纤溶酶的形成和细胞外基质蛋白的周转,从而促进肿瘤细胞的迁移/侵袭。矛盾的是,u-PAR依赖的蛋白分解作用的减弱有利于血栓包裹的肿瘤细胞,因为它保持了纤维蛋白的完整性,将肿瘤细胞与淋巴因子激活的杀伤细胞隔离开来。我们已经做了一个有趣的观察,在一些结肠癌细胞中,克隆群体在高和低细胞表面密度之间振荡,与后者分离的致瘤性降低。有趣的是,改变后的u-PAR细胞表面显示本质上是翻译后的。在特定的目标#1中,我们将确定u-PAR显示可塑性在结肠癌中的流行率,如果肿瘤发生/休眠状态的改变反映了细胞表面u-PAR密度的这种波动,以及向下转移到低u-PAR的亚群在保护LAK细胞的杀伤活性方面是否具有优势。在特定的目标#2中,我们将确定u-PAR缺陷人群中u-PAR的糖基化改变是否是未成熟蛋白溶酶体降解的初始刺激因素。
英文摘要
A strong body of work has implicated the cell surface urokinase receptor (u-PAR) in modulating tumor growth and progression. Elevated u-PAR levels yield increased growth while low u-PAR promotes tumor dormancy the latter protective against microenvironmental stress such as hypoxia, nutrient deprivation. The u- PAR also binds the serine protease urokinase thus increasing plasmin formation and extracellular matrix protein turnover to promote tumor cell migration/invasion. Paradoxically, diminished u-PAR-dependent proteolysis benefits thrombus-enveloped tumor cells by virtue of maintaining the integrity of the fibrin “cloaking” the tumor cells from lymphokine-activated killer cells. We have made the intriguing observation that in some colon cancer cells, clonal populations oscillate in u-PAR display between high and low cell surface density with reduced tumorigenecity segregating with the latter. Interestingly, the altered u-PAR cell surface display is posttranslational in nature. In Specific Aim #1 we will determine the prevalence of u-PAR display plasticity in colon cancer, if altered tumorigenecity/dormancy mirrors this oscillation in cell surface u-PAR density and whether the sub-population down-shifted to low u-PAR has an advantage with respect to protection from the killing activity of LAK cells. In Specific Aim # 2, we will determine whether altered glycosylation of u-PAR in the u-PARdeficient population is an initial stimulus for lysosomal degradation of the immature protein.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1016/j.molcel.2013.01.024
发表时间:
2013-04-11
期刊:
MOLECULAR CELL
影响因子:
16
作者:
[Chauhan, Santosh, Goodwin, Jinesh G., Chauhan, Swati, Manyam, Ganiraju, Wang, Jing, Kamat, Ashish M., Boyd, Douglas D.]
通讯作者:
Boyd, Douglas D.
A bisanthracycline (WP631) represses uPAR gene expression and cell migration of RKO colon cancer cells by interfering with transcription factor binding to a chromatin-accessible -148/-124 promoter region.
双蒽环霉素 (WP631) 通过干扰转录因子与染色质可及的 -148/-124 启动子区域的结合来抑制 RKO 结肠癌细胞的 uPAR 基因表达和细胞迁移。
DOI:
10.3727/096504005776404571
发表时间:
2005
期刊:
Oncology research
影响因子:
3.1
作者:
[Nair,RajeshR, Wang,Heng, Jamaluddin,MS, Fokt,Izabella, Priebe,Waldemar, Boyd,DouglasD]
通讯作者:
Boyd,DouglasD
Plasticity in urokinase-type plasminogen activator receptor (uPAR) display in colon cancer yields metastable subpopulations oscillating in cell surface uPAR density--implications in tumor progression.
结肠癌中尿激酶型纤溶酶原激活剂受体 (uPAR) 显示的可塑性产生细胞表面 uPAR 密度振荡的亚稳态亚群,这对肿瘤进展有影响。
DOI:
10.1158/0008-5472.can-05-3208
发表时间:
2006
期刊:
Cancer research
影响因子:
11.2
作者:
[Yang,Lin, Avila,Hector, Wang,Heng, Trevino,Jose, Gallick,GaryE, Kitadai,Yasuhiko, Sasaki,Takamitsu, Boyd,DouglasD]
通讯作者:
Boyd,DouglasD
Src requirement for u-PAR expression by HGF and hypoxia
-
批准号:6922046
-
项目类别:
-
资助金额:$25.1万
-
财政年份:2003
-
负责人:Douglas D. Boyd
-
依托单位:
Src requirement for u-PAR expression by HGF and hypoxia
-
批准号:6739102
-
项目类别:
-
资助金额:$25.1万
-
财政年份:2003
-
负责人:Douglas D. Boyd
-
依托单位:
Src requirement for u-PAR expression by HGF and hypoxia
-
批准号:6575882
-
项目类别:
-
资助金额:$25.1万
-
财政年份:2003
-
负责人:Douglas D. Boyd
-
依托单位:
ROLE OF THE UROKINASE RECEPTOR IN INVASIVE COLON CANCER
-
批准号:2099003
-
项目类别:
-
资助金额:$13.75万
-
财政年份:1994
-
负责人:Douglas D. Boyd
-
依托单位:
UROKINASE RECEPTOR EXPRESSION--COLON CANCER
-
批准号:6171928
-
项目类别:
-
资助金额:$19.76万
-
财政年份:1994
-
负责人:Douglas D. Boyd
-
依托单位:
Regulation of urokinase receptor expression in colon CA
-
批准号:7058227
-
项目类别:
-
资助金额:$25.8万
-
财政年份:1994
-
负责人:Douglas D. Boyd
-
依托单位:
Regulation of urokinase receptor expression in colon CA
-
批准号:6607838
-
项目类别:
-
资助金额:$26.43万
-
财政年份:1994
-
负责人:Douglas D. Boyd
-
依托单位:
ROLE OF THE UROKINASE RECEPTOR IN INVASIVE COLON CANCER
-
批准号:2099004
-
项目类别:
-
资助金额:$14.3万
-
财政年份:1994
-
负责人:Douglas D. Boyd
-
依托单位:
PROTEASE EXPRESSION IN ORAL CANCER
-
批准号:6350581
-
项目类别:
-
资助金额:$19.7万
-
财政年份:1994
-
负责人:Douglas D. Boyd
-
依托单位:
PROTEASE EXPRESSION IN ORAL CANCER
-
批准号:6150523
-
项目类别:
-
资助金额:$19.13万
-
财政年份:1994
-
负责人:Douglas D. Boyd
-
依托单位:
PROTEASE EXPRESSION IN ORAL CANCER
-
批准号:2872151
-
项目类别:
-
资助金额:$18.57万
-
财政年份:1994
-
负责人:Douglas D. Boyd
-
依托单位:
IMPORTANCE OF EXPRESSION OF PROTEASES IN ORAL CANCER
-
批准号:2131743
-
项目类别:
-
资助金额:$13.13万
-
财政年份:1994
-
负责人:Douglas D. Boyd
-
依托单位:
Regulation of type IV collagenase expression
-
批准号:6984074
-
项目类别:
-
资助金额:$25.8万
-
财政年份:1994
-
负责人:Douglas D. Boyd
-
依托单位:
Regulation of urokinase receptor expression in colon cancer
-
批准号:7231429
-
项目类别:
-
资助金额:$25.06万
-
财政年份:1994
-
负责人:Douglas D. Boyd
-
依托单位:
Regulation of urokinase receptor expression in colon cancer
-
批准号:7622899
-
项目类别:
-
资助金额:$28.76万
-
财政年份:1994
-
负责人:Douglas D. Boyd
-
依托单位:
UROKINASE RECEPTOR EXPRESSION--COLON CANCER
-
批准号:2894991
-
项目类别:
-
资助金额:$19.18万
-
财政年份:1994
-
负责人:Douglas D. Boyd
-
依托单位:
UROKINASE RECEPTOR EXPRESSION--COLON CANCER
-
批准号:2700491
-
项目类别:
-
资助金额:$18.62万
-
财政年份:1994
-
负责人:Douglas D. Boyd
-
依托单位:
UROKINASE RECEPTOR EXPRESSION--COLON CANCER
-
批准号:6375960
-
项目类别:
-
资助金额:$20.35万
-
财政年份:1994
-
负责人:Douglas D. Boyd
-
依托单位:
UROKINASE RECEPTOR EXPRESSION--COLON CANCER
-
批准号:2393435
-
项目类别:
-
资助金额:$18.08万
-
财政年份:1994
-
负责人:Douglas D. Boyd
-
依托单位:
PROTEASE EXPRESSION IN ORAL CANCER
-
批准号:2015135
-
项目类别:
-
资助金额:$17.51万
-
财政年份:1994
-
负责人:Douglas D. Boyd
-
依托单位:
海外基金